Professional Seasonal Analysis for Trading

NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN)

Seasonality Analysis

Stocks 5 Years Analyzed

NeuroSense Therapeutics Ltd. - Ordinary Shares Annual Seasonality Statistics

50.27%
Avg Annual Return
39.6%
Avg Monthly Win Rate
7/12
Positive Months
5
Years Analyzed

NeuroSense Therapeutics Ltd. - Ordinary Shares Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 11.69%
60%
Moderate
February 15.37%
60%
Moderate
March 10.17%
20%
Weak
April -12.17%
40%
Weak
May -0.51%
25%
Very Weak
June 36.82%
50%
Weak
July -22.45%
0%
Very Weak
August 2.40%
50%
Weak
September 4.67%
50%
Weak
October -13.60%
25%
Very Weak
November BEST 44.59%
75%
Very Strong
December WORST -26.72%
20%
Very Weak

NeuroSense Therapeutics Ltd. - Ordinary Shares 2026 vs Historical Pattern

Current Position
8.95
Historical Avg Position
42.26
Deviation
-33.31
Performance
Significantly Below Average

NeuroSense Therapeutics Ltd. - Ordinary Shares Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for NRSN with overlay patterns, custom date ranges, and more.

Create Free Account

NeuroSense Therapeutics Ltd. - Ordinary Shares Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

NeuroSense Therapeutics Ltd. - Ordinary Shares Seasonal Historical Performance

Historical Performance

See historical average returns for NRSN across multiple timeframes.

Create Free Account

About NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN) Seasonality

NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN) has been analyzed using 5 years of historical data to identify seasonal patterns. Classified under Stocks, NeuroSense Therapeutics Ltd. - Ordinary Shares shows distinct seasonal tendencies based on historical data.

The strongest month for NeuroSense Therapeutics Ltd. - Ordinary Shares is historically November, with an average return of 44.59% and a win rate of 75%. Conversely, December tends to be the weakest month, averaging -26.72% return.

Looking at the full calendar year, NeuroSense Therapeutics Ltd. - Ordinary Shares has an average annual return of 50.27% with an overall monthly win rate of 39.6%. Out of 12 months, 7 typically show positive average returns.

The seasonal pattern for NeuroSense Therapeutics Ltd. - Ordinary Shares has a consistency score of 56.7 (Fair), based on 6 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

NeuroSense Therapeutics Ltd. - Ordinary Shares Seasonality FAQ

What is the best month to buy NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN)?

Historically, November has been the best month for NeuroSense Therapeutics Ltd. - Ordinary Shares, with an average return of 44.59% and a win rate of 75%. However, past performance does not guarantee future results.

What is the worst month for NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN)?

Based on historical data, December has been the weakest month for NeuroSense Therapeutics Ltd. - Ordinary Shares, with an average return of -26.72%. This is a historical observation and does not guarantee future results.

How reliable is NRSN seasonality data?

The seasonality analysis for NeuroSense Therapeutics Ltd. - Ordinary Shares is based on 5 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use NeuroSense Therapeutics Ltd. - Ordinary Shares seasonality in my trading?

Use NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.